发明名称 КОНДЕНСИРОВАННОЕ 4-ОКСОПИРИМИДИНОВОЕ ПРОИЗВОДНОЕ
摘要 The present invention provides a compound represented by formula (I) below, or a pharmaceutically acceptable salt thereof, which, having histamine H3 receptor antagonist or inverse agonist activity, is useful in the prophylaxis or therapy of metabolic diseases, circulatory diseases, or nervous system diseases. [where, for example, Ar is a divalent group formed by eliminating two hydrogen atoms from benzene, X 1 is a nitrogen atom, sulfur atom or oxygen atom, R 1 is a 5- to 6-membered heteroaryl group, Ring A is a 5- to 6-membered heteroaryl ring, R 2 and R 3 are amino groups or alkylamino groups, and X 2 is represented by formula (II): (where R 4 and R 5 are lower alkyl groups, and n is an integer from 2 to 4).]
申请公布号 RU2006132729(A) 申请公布日期 2008.03.20
申请号 RU20060132729 申请日期 2005.02.14
申请人 БАНИУ ФАРМАСЬЮТИКАЛ КО., ЛТД. (JP) 发明人 НАГАСЕ Тсуеси (JP);САТО Нагааки (JP);КАНАТАНИ Акио (JP);ТОКИТА Сигеру (JP)
分类号 C07D217/24;A61K31/4725;A61K31/517;A61K31/519;A61K31/55;A61K45/06;A61P1/16;A61P3/04;A61P3/06;A61P3/10;A61P3/12;A61P5/00;A61P9/00;A61P9/04;A61P9/10;A61P9/12;A61P13/12;A61P19/06;A61P25/02;A61P25/08;A61P25/14;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P25/36;A61P43/00;C07D239/70;C07D239/91;C07D401/04;C07D401/12;C07D403/04;C07D403/12;C07D471/04;C07D487/08 主分类号 C07D217/24
代理机构 代理人
主权项
地址